NURS 5434 FAMILY III FINAL AND PRACTICE EXAM
(UTA) {2 VERSIONS} QUESTIONS WITH ANSWERS
AND RATIONALES (2026 EDITION) Latest Update This
Year Instant Download Pdf
Typical content emphasis for UTA’s NURS 5434 Family III FNP course:
Adult wellness & prevention
Psychiatric/behavioral health in primary care
Cardiometabolic conditions (HTN, lipids, CAD, diabetes, obesity, metabolic
syndrome)
Complex/chronic disease management across the lifespan
Clinical reasoning, guidelines, and pharmacotherapy for FNP
Format: single best answer, correct option in bold, with a brief rationale. Use this as a
study aid only, not as the real UTA exam.
Adult Wellness, Prevention & Cardiometabolic Foundations (Q1–30)
1. Which lipid fraction is most strongly associated with atherosclerotic
cardiovascular disease (ASCVD)?
A. HDL
B. LDL
C. Triglycerides
D. VLDL
Elevated LDL is the primary driver of plaque formation and ASCVD risk.
2. First-line pharmacologic therapy for hyperlipidemia in ASCVD prevention is:
A. Niacin
B. Statins
,C. Fibrates
D. Fish oil
Statins reduce LDL and ASCVD events and are cornerstone therapy.
3. Which lifestyle modification most effectively lowers LDL cholesterol?
A. Increased physical activity alone
B. Reduced saturated and trans fat intake
C. Omega-3 supplementation alone
D. Smoking cessation alone
Diet low in saturated/trans fats directly lowers LDL.
4. Which lipid abnormality is most common in metabolic syndrome?
A. High HDL
B. Low LDL
C. Elevated triglycerides
D. Low total cholesterol
Metabolic syndrome often presents with high TG and low HDL.
5. Which statin is considered high-intensity?
A. Pravastatin 40 mg
B. Simvastatin 20 mg
C. Atorvastatin 80 mg
D. Lovastatin 40 mg
High-intensity statins lower LDL ≥50%.
6. Which patient group benefits most from statin therapy?
A. Adults with LDL <70 mg/dL
B. Adults with clinical ASCVD
C. Children under 12
D. Adults with HDL >60 mg/dL
,Secondary prevention in ASCVD patients is the strongest indication.
7. Which lab should be monitored with statin therapy?
A. CBC
B. Liver function tests (LFTs)
C. Thyroid panel
D. Vitamin D
Statins may cause hepatotoxicity; baseline and follow-up LFTs are recommended.
8. Which lipid-lowering drug is contraindicated in pregnancy?
A. Omega-3 fatty acids
B. Bile acid sequestrants
C. Statins
D. Niacin
Statins are teratogenic and contraindicated in pregnancy.
9. Which lipid abnormality is most strongly linked to pancreatitis?
A. High LDL
B. Low HDL
C. Triglycerides >500 mg/dL
D. Elevated total cholesterol
Severe hypertriglyceridemia increases pancreatitis risk.
10. Which non-statin agent lowers LDL by inhibiting intestinal cholesterol
absorption?
A. Fibrate
B. Niacin
C. Ezetimibe
D. Fish oil
Ezetimibe blocks cholesterol absorption in the gut.
, 11. Which lipoprotein is considered “protective” against CAD?
A. LDL
B. VLDL
C. HDL
D. IDL
HDL facilitates reverse cholesterol transport.
12. Which patient should be started on statin therapy regardless of LDL level?
A. 25-year-old with LDL 120 mg/dL
B. 40–75-year-old with diabetes
C. 40-year-old with HDL 65 mg/dL
D. 30-year-old with triglycerides 200 mg/dL
Diabetes in this age range is a statin benefit group.
13. According to ACC/AHA, which BP range defines Stage 1 hypertension?
A. 120–129/<80
B. 130–139 or 80–89 mmHg
C. 140–159 or 90–99 mmHg
D. ≥160/100 mmHg
ACC/AHA define Stage 1 HTN as 130–139/80–89.
14. A 55-year-old with BP 142/88 on two visits, no comorbidities. What is the
diagnosis?
A. Normal
B. Elevated
C. Stage 1 hypertension
D. Stage 2 hypertension
140–159 systolic is Stage 2 under older JNC, but ACC/AHA: Stage 2 ≥140/90; 142/88 is
Stage 2 by ACC/AHA.
(UTA) {2 VERSIONS} QUESTIONS WITH ANSWERS
AND RATIONALES (2026 EDITION) Latest Update This
Year Instant Download Pdf
Typical content emphasis for UTA’s NURS 5434 Family III FNP course:
Adult wellness & prevention
Psychiatric/behavioral health in primary care
Cardiometabolic conditions (HTN, lipids, CAD, diabetes, obesity, metabolic
syndrome)
Complex/chronic disease management across the lifespan
Clinical reasoning, guidelines, and pharmacotherapy for FNP
Format: single best answer, correct option in bold, with a brief rationale. Use this as a
study aid only, not as the real UTA exam.
Adult Wellness, Prevention & Cardiometabolic Foundations (Q1–30)
1. Which lipid fraction is most strongly associated with atherosclerotic
cardiovascular disease (ASCVD)?
A. HDL
B. LDL
C. Triglycerides
D. VLDL
Elevated LDL is the primary driver of plaque formation and ASCVD risk.
2. First-line pharmacologic therapy for hyperlipidemia in ASCVD prevention is:
A. Niacin
B. Statins
,C. Fibrates
D. Fish oil
Statins reduce LDL and ASCVD events and are cornerstone therapy.
3. Which lifestyle modification most effectively lowers LDL cholesterol?
A. Increased physical activity alone
B. Reduced saturated and trans fat intake
C. Omega-3 supplementation alone
D. Smoking cessation alone
Diet low in saturated/trans fats directly lowers LDL.
4. Which lipid abnormality is most common in metabolic syndrome?
A. High HDL
B. Low LDL
C. Elevated triglycerides
D. Low total cholesterol
Metabolic syndrome often presents with high TG and low HDL.
5. Which statin is considered high-intensity?
A. Pravastatin 40 mg
B. Simvastatin 20 mg
C. Atorvastatin 80 mg
D. Lovastatin 40 mg
High-intensity statins lower LDL ≥50%.
6. Which patient group benefits most from statin therapy?
A. Adults with LDL <70 mg/dL
B. Adults with clinical ASCVD
C. Children under 12
D. Adults with HDL >60 mg/dL
,Secondary prevention in ASCVD patients is the strongest indication.
7. Which lab should be monitored with statin therapy?
A. CBC
B. Liver function tests (LFTs)
C. Thyroid panel
D. Vitamin D
Statins may cause hepatotoxicity; baseline and follow-up LFTs are recommended.
8. Which lipid-lowering drug is contraindicated in pregnancy?
A. Omega-3 fatty acids
B. Bile acid sequestrants
C. Statins
D. Niacin
Statins are teratogenic and contraindicated in pregnancy.
9. Which lipid abnormality is most strongly linked to pancreatitis?
A. High LDL
B. Low HDL
C. Triglycerides >500 mg/dL
D. Elevated total cholesterol
Severe hypertriglyceridemia increases pancreatitis risk.
10. Which non-statin agent lowers LDL by inhibiting intestinal cholesterol
absorption?
A. Fibrate
B. Niacin
C. Ezetimibe
D. Fish oil
Ezetimibe blocks cholesterol absorption in the gut.
, 11. Which lipoprotein is considered “protective” against CAD?
A. LDL
B. VLDL
C. HDL
D. IDL
HDL facilitates reverse cholesterol transport.
12. Which patient should be started on statin therapy regardless of LDL level?
A. 25-year-old with LDL 120 mg/dL
B. 40–75-year-old with diabetes
C. 40-year-old with HDL 65 mg/dL
D. 30-year-old with triglycerides 200 mg/dL
Diabetes in this age range is a statin benefit group.
13. According to ACC/AHA, which BP range defines Stage 1 hypertension?
A. 120–129/<80
B. 130–139 or 80–89 mmHg
C. 140–159 or 90–99 mmHg
D. ≥160/100 mmHg
ACC/AHA define Stage 1 HTN as 130–139/80–89.
14. A 55-year-old with BP 142/88 on two visits, no comorbidities. What is the
diagnosis?
A. Normal
B. Elevated
C. Stage 1 hypertension
D. Stage 2 hypertension
140–159 systolic is Stage 2 under older JNC, but ACC/AHA: Stage 2 ≥140/90; 142/88 is
Stage 2 by ACC/AHA.
